BIVI
Price:
$2.06
Market Cap:
$36.60M
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease and Phase I clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to Bio...[Read more]
Industry
Biotechnology
IPO Date
2020-09-18
Stock Exchange
NASDAQ
Ticker
BIVI
According to BioVie Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 20.30M. This represents a change of 99.16% compared to the average of 10.19M of the last 4 quarters.
The mean historical Enterprise Value of BioVie Inc. over the last ten years is 50.68M. The current 20.30M Enterprise Value has changed 3.90% with respect to the historical average. Over the past ten years (40 quarters), BIVI's Enterprise Value was at its highest in in the March 2023 quarter at 265.18M. The Enterprise Value was at its lowest in in the September 2024 quarter at -8628737.00.
Average
50.68M
Median
27.53M
Minimum
1.11M
Maximum
205.67M
Discovering the peaks and valleys of BioVie Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 761.43%
Maximum Annual Enterprise Value = 205.67M
Minimum Annual Increase = -99.18%
Minimum Annual Enterprise Value = 1.11M
Year | Enterprise Value | Change |
---|---|---|
2024 | 1.11M | -99.18% |
2023 | 134.69M | 359.80% |
2022 | 29.29M | -85.76% |
2021 | 205.67M | 194.85% |
2020 | 69.75M | 134.83% |
2019 | 29.70M | 402.59% |
2018 | 5.91M | -77.06% |
2017 | 25.77M | 761.43% |
2016 | 2.99M | 58.37% |
2015 | 1.89M | 3.59% |
The current Enterprise Value of BioVie Inc. (BIVI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
55.03M
5-year avg
88.10M
10-year avg
50.68M
BioVie Inc.’s Enterprise Value is less than Inozyme Pharma, Inc. (215.58M), less than Day One Biopharmaceuticals, Inc. (859.59M), less than Terns Pharmaceuticals, Inc. (234.86M), less than Eledon Pharmaceuticals, Inc. (244.06M), greater than HOOKIPA Pharma Inc. (-37325309.00), less than X4 Pharmaceuticals, Inc. (79.21M), less than Acumen Pharmaceuticals, Inc. (103.15M), less than Mereo BioPharma Group plc (445.16M), less than Amylyx Pharmaceuticals, Inc. (209.72M),
Company | Enterprise Value | Market cap |
---|---|---|
215.58M | $193.36M | |
859.59M | $1.28B | |
234.86M | $503.69M | |
244.06M | $250.31M | |
-37325309.00 | $19.60M | |
79.21M | $98.42M | |
103.15M | $106.34M | |
445.16M | $524.55M | |
209.72M | $278.99M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioVie Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioVie Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is BioVie Inc.'s Enterprise Value?
What is the highest Enterprise Value for BioVie Inc. (BIVI)?
What is the 3-year average Enterprise Value for BioVie Inc. (BIVI)?
What is the 5-year average Enterprise Value for BioVie Inc. (BIVI)?
How does the current Enterprise Value for BioVie Inc. (BIVI) compare to its historical average?